HomeCompareGBIO vs SPHD

GBIO vs SPHD: Dividend Comparison 2026

GBIO yields 37.45% · SPHD yields 4.33%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GBIO wins by $175.1K in total portfolio value
10 years
GBIO
GBIO
● Live price
37.45%
Share price
$5.34
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$201.6K
Annual income
$32,248.55
Full GBIO calculator →
SPHD
SPHD
● Live price
4.33%
Share price
$49.34
Annual div
$2.14
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.5K
Annual income
$571.32
Full SPHD calculator →

Portfolio growth — GBIO vs SPHD

📍 GBIO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGBIOSPHD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GBIO + SPHD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GBIO pays
SPHD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GBIO
Annual income on $10K today (after 15% tax)
$3,183.52/yr
After 10yr DRIP, annual income (after tax)
$27,411.27/yr
SPHD
Annual income on $10K today (after 15% tax)
$367.92/yr
After 10yr DRIP, annual income (after tax)
$485.62/yr
At 15% tax rate, GBIO beats the other by $26,925.65/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GBIO + SPHD for your $10,000?

GBIO: 50%SPHD: 50%
100% SPHD50/50100% GBIO
Portfolio after 10yr
$114.1K
Annual income
$16,409.93/yr
Blended yield
14.38%
📊

Analyst Conviction Gap

Where Wall Street is split right now

GBIO
No analyst data
Price Target
$5.25
-1.7% upside vs current
Range: $5.00 — $5.50
Altman Z
-9.1
Piotroski
1/9
SPHD
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GBIO buys
0
SPHD buys
0
No recent congressional trades found for GBIO or SPHD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGBIOSPHD
Forward yield37.45%4.33%
Annual dividend / share$2.00$2.14
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$201.6K$26.5K
Annual income after 10y$32,248.55$571.32
Total dividends collected$148.7K$5.1K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: GBIO vs SPHD ($10,000, DRIP)

YearGBIO PortfolioGBIO Income/yrSPHD PortfolioSPHD Income/yrGap
1← crossover$14,445$3,745.32$11,133$432.85+$3.3KGBIO
2$20,513$5,056.29$12,363$450.36+$8.2KGBIO
3$28,659$6,710.36$13,695$467.39+$15.0KGBIO
4$39,427$8,761.91$15,138$483.90+$24.3KGBIO
5$53,452$11,265.44$16,697$499.88+$36.8KGBIO
6$71,468$14,273.72$18,382$515.31+$53.1KGBIO
7$94,307$17,835.96$20,198$530.17+$74.1KGBIO
8$122,904$21,996.02$22,157$544.46+$100.7KGBIO
9$158,298$26,790.73$24,266$558.18+$134.0KGBIO
10$201,627$32,248.55$26,536$571.32+$175.1KGBIO

GBIO vs SPHD: Complete Analysis 2026

GBIOStock

Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.

Full GBIO Calculator →

SPHDETF

The Invesco S&P 500 High Dividend Low Volatility ETF (Fund) is based on the S&P 500 Low Volatility High Dividend Index (Index). The Fund will invest at least 90% of its total assets in common stocks that comprise the Index. Standard & Poor's compiles, maintains and calculates the Index, which is composed of 50 securities traded on the S&P 500 Index that historically have provided high dividend yields and low volatility. The Fund and the Index are rebalanced and reconstituted semi-annually, in January and July.

Full SPHD Calculator →
📬

Get this GBIO vs SPHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GBIO vs SCHDGBIO vs JEPIGBIO vs OGBIO vs KOGBIO vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.